000			02367 a2200649 4500
005			20250514002253.0
264		0	_c20010705
008			200107s 0 0 eng d
022			_a0732-183X
024	7		_a10.1200/JCO.2001.19.12.3103 _2doi
040			_aNLM _beng _cNLM
100	1		_aPiccart, M J
245	0	0	_aPhase III trial comparing two dose levels of epirubicin combined with cyclophosphamide with cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer. _h[electronic resource]
260			_bJournal of clinical oncology : official journal of the American Society of Clinical Oncology _cJun 2001
300			_a3103-10 p. _bdigital
500			_aPublication Type: Clinical Trial; Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects
650	0	4	_aBelgium _xepidemiology
650	0	4	_aBreast Neoplasms _xdrug therapy
650	0	4	_aChemotherapy, Adjuvant _xmethods
650	0	4	_aCyclophosphamide _xadministration & dosage
650	0	4	_aDisease-Free Survival
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aEpirubicin _xadministration & dosage
650	0	4	_aFemale
650	0	4	_aFluorouracil _xadministration & dosage
650	0	4	_aHumans
650	0	4	_aMethotrexate _xadministration & dosage
650	0	4	_aMiddle Aged
650	0	4	_aPrognosis
650	0	4	_aProportional Hazards Models
650	0	4	_aStatistics, Nonparametric
650	0	4	_aSurvival Rate
700	1		_aDi Leo, A
700	1		_aBeauduin, M
700	1		_aVindevoghel, A
700	1		_aMichel, J
700	1		_aFocan, C
700	1		_aTagnon, A
700	1		_aRies, F
700	1		_aGobert, P
700	1		_aFinet, C
700	1		_aCloson-Dejardin, M T
700	1		_aDufrane, J P
700	1		_aKerger, J
700	1		_aLiebens, F
700	1		_aBeauvois, S
700	1		_aBartholomeus, S
700	1		_aDolci, S
700	1		_aLobelle, J P
700	1		_aPaesmans, M
700	1		_aNogaret, J M
773	0		_tJournal of clinical oncology : official journal of the American Society of Clinical Oncology _gvol. 19 _gno. 12 _gp. 3103-10
856	4	0	_uhttps://doi.org/10.1200/JCO.2001.19.12.3103 _zAvailable from publisher's website
999			_c11338724 _d11338724